Invention Grant
US08324368B2 GNAQ targeted dsRNA compositions and methods for inhibiting expression
有权
GNAQ靶向dsRNA组合物和抑制表达的方法
- Patent Title: GNAQ targeted dsRNA compositions and methods for inhibiting expression
- Patent Title (中): GNAQ靶向dsRNA组合物和抑制表达的方法
-
Application No.: US12635630Application Date: 2009-12-10
-
Publication No.: US08324368B2Publication Date: 2012-12-04
- Inventor: Jared Gollob , Gregory Hinkle , Ivanka Toudjarska , David Bumcrot
- Applicant: Jared Gollob , Gregory Hinkle , Ivanka Toudjarska , David Bumcrot
- Applicant Address: US MA Cambridge
- Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Fenwick & West LLP
- Main IPC: C07H21/02
- IPC: C07H21/02 ; C07H21/04 ; C12N15/58 ; A01N43/04 ; C12Q1/68
Abstract:
The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting a G-alpha q subunit (GNAQ) of a heterotrimeric G gene, and methods of using the dsRNA to inhibit expression of GNAQ.
Public/Granted literature
- US20100168206A1 GNAQ Targeted dsRNA Compositions And Methods For Inhibiting Expression Public/Granted day:2010-07-01
Information query
